|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Targeting acetylcholinesterase and utyrylcholinesterase in dementia 显示文摘 | Lane M Potkin G Enz A | 2005 | Int J Neuropsychopharmacol2005，8，： | 1 |
| 2 | Optical and luminescent properties of anisotropic tractate crystals显示文摘 | Kolobanov V N Kamenskikh I A Mikhailin V V Shpinkov I N Spessky D A Zadneprovsky B I Potkin L I Zimmerer G | 2002 | Nuclear Instruments and Methods in Physics Research A2002，486，： | 1 |
| 3 | Aripiprazole,an antipsychotic with a novel mechanism of action,and risperidone vs placebo in patients with schizophrenia and schizoafective disorder显示文摘 | POTKIN S G SAHA A R KUJAWA M J | 2003 | Arch Gen Psychiatry2003，60，7： | 1 |
| 4 | Targeting acetylcholinesterase and utyrylcholinesterase in dementia 显示文摘 | Lane M Potkin G Enz A | 2005 | Int J Neuropsychopharmacol2005，8，： | 1 |
| 5 | Zip 80mg/d and 160mg/d in the acute Exacerbation of schizophrenia and schizoaffective disorder: A 6 week placebo controlled trial zip study gmup显示文摘 | Daniel D G zimbroff D L potkin S G | 1999 | Neuropsychopharma- cology1999，20，5： | 1 |
| 6 | The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine显示文摘 | Potkin SG Thyrum PT Alva G | 2002 | J Clin Psychopharmacol2002，22，2： | 1 |
| 7 | 1-Adamantanecarboxylic acid esters of certain terpenols,sterols,and plant phenols显示文摘 | Dikusar E A Kozlov N G Potkin V L | 2003 | Chemistry of Natural Compound2003，39，3： | 1 |
| 8 | A PET study of the pathophysiology of negative symptoms in schizophrenia显示文摘 | Potkin SG Alva G Fleming K | 2002 | Am J Psychiatry2002，159，2： | 1 |
| 9 | The safety and pharmacokinetice of quetiapine when coadministered with haloperidol,risperidone,or thioridazine显示文摘 | Potkin SG Thyrum PT Alva G | 2002 | J clin Psychopharmacol2002，22，2： | 1 |
| 10 | Targeting acety Jcholinesterase and butyrylcholinesterase in dementia显示文摘 | Lane M Potkin G Enz A | 2005 | Int J Neuropsychol Pharmacol2005，8，： | 1 |
| 11 | A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiting hospitalization显示文摘 | Steven G Potkin a Georges M | 2006 | Schizophrenia Research2006，，85： | 1 |
| 12 | Targeting acetyleholinesterase and butyrylcholinesterase in dementia 显示文摘 | Lane M Potkin G Enz A | 2006 | Int J Neuropsychol Pharmacol2006，9，1： | 1 |
| 13 | Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disordcr显示文摘 | Potkin S G Saha A R Kujawa M J | 2003 | Arch Gen Psychiatry2003，7，6： | 1 |
| 14 | Aripiprazole,an antipsychotic with a novel mechanism of action,and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder显示文摘 | S G Potkin A R Saha M J Kujawa | | 0，，07： | 1 |
| 15 | Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: methodological considerations 显示文摘 | Potkin SG Turner JA Guffanti G | 2009 | Cogn Neuropsychiatry2009，14，45： | 1 |
| 16 | Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine显示文摘 | Potkin SG Thyrum PT Alva G | 2002 | J Clin Psychopharmacol2002，22，13： | 1 |
| 17 | Memantine treatment in mild to moderate Alzheimer's disease:a 24-week randomized, controlled trial 显示文摘 | PESKIND E R POTKIN S G POMARA N | 2006 | Am J Geriatr Psychiatry2006，14，6： | 1 |
| 18 | Efficacy and tolerability of asenapine in acute schizophrenia:a placebo-and risperidone-controlled trial显示文摘 | Potkin S G Cohen M Panagides J | 2007 | J Clin Psychiatry2007，68，10： | 1 |
| 19 | Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine显示文摘 | Potkin SG Thyrum PT Alva G | 2002 | J Clin Psychopharmacol2002，22，2： | 1 |
| 20 | Aripiprazole,an antipsy-chotic with a novel mechanism of action,and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder显示文摘 | Potkin S G Saha A R Kujawa M J | 2003 | Arch Gen Psychiatry2003，60，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员